Market Closed -
TEL AVIV STOCK EXCHANGE
10:24:11 2024-06-10 am EDT
|
5-day change
|
1st Jan Change
|
956.9
ILa
|
+0.84%
|
|
+0.41%
|
-20.92%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
4,941
|
6,866
|
3,174
|
3,683
|
1,707
|
1,930
|
Enterprise Value (EV)
1 |
31,598
|
28,051
|
26,529
|
23,660
|
24,320
|
24,521
|
P/E ratio
|
-19.7
x
|
10.9
x
|
-5.35
x
|
5.79
x
|
-1.31
x
|
-1.78
x
|
Yield
|
5.85%
|
4.24%
|
7.58%
|
4.88%
|
12%
|
-
|
Capitalization / Revenue
|
1.53
x
|
2.46
x
|
1.36
x
|
1.58
x
|
0.76
x
|
0.79
x
|
EV / Revenue
|
9.79
x
|
10.1
x
|
11.4
x
|
10.1
x
|
10.8
x
|
10.1
x
|
EV / EBITDA
|
15.8
x
|
17.2
x
|
21.7
x
|
18.2
x
|
20.8
x
|
29.8
x
|
EV / FCF
|
-491
x
|
36
x
|
-57.7
x
|
24
x
|
-94.8
x
|
-92.7
x
|
FCF Yield
|
-0.2%
|
2.78%
|
-1.73%
|
4.17%
|
-1.05%
|
-1.08%
|
Price to Book
|
0.53
x
|
0.85
x
|
0.55
x
|
0.7
x
|
0.36
x
|
0.47
x
|
Nbr of stocks (in thousands)
|
190,053
|
179,646
|
151,346
|
149,791
|
159,525
|
159,525
|
Reference price
2 |
26.00
|
38.22
|
20.97
|
24.59
|
10.70
|
12.10
|
Announcement Date
|
3/18/19
|
4/7/20
|
3/31/21
|
3/23/22
|
3/29/23
|
4/11/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
3,229
|
2,789
|
2,328
|
2,337
|
2,252
|
2,436
|
EBITDA
1 |
2,006
|
1,634
|
1,220
|
1,298
|
1,168
|
824
|
EBIT
1 |
1,940
|
1,603
|
1,192
|
1,271
|
1,144
|
795
|
Operating Margin
|
60.08%
|
57.48%
|
51.2%
|
54.39%
|
50.8%
|
32.64%
|
Earnings before Tax (EBT)
1 |
-111
|
1,283
|
-1,033
|
1,729
|
-1,554
|
-1,200
|
Net income
1 |
-253
|
655
|
-653
|
646
|
-1,340
|
-1,203
|
Net margin
|
-7.84%
|
23.49%
|
-28.05%
|
27.64%
|
-59.5%
|
-49.38%
|
EPS
2 |
-1.319
|
3.495
|
-3.923
|
4.250
|
-8.153
|
-6.795
|
Free Cash Flow
1 |
-64.38
|
778.9
|
-459.9
|
986
|
-256.5
|
-264.5
|
FCF margin
|
-1.99%
|
27.93%
|
-19.75%
|
42.19%
|
-11.39%
|
-10.86%
|
FCF Conversion (EBITDA)
|
-
|
47.67%
|
-
|
75.96%
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
118.91%
|
-
|
152.63%
|
-
|
-
|
Dividend per Share
2 |
1.520
|
1.620
|
1.590
|
1.200
|
1.280
|
-
|
Announcement Date
|
3/18/19
|
4/7/20
|
3/31/21
|
3/23/22
|
3/29/23
|
4/11/24
|
Fiscal Period: December |
2022 Q3
|
---|
Net sales
|
-
|
EBITDA
|
-
|
EBIT
|
-
|
Operating Margin
|
-
|
Earnings before Tax (EBT)
|
-
|
Net income
1 |
-16
|
Net margin
|
-
|
EPS
2 |
-0.1000
|
Dividend per Share
|
-
|
Announcement Date
|
11/16/22
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
26,657
|
21,185
|
23,355
|
19,977
|
22,613
|
22,591
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
13.29
x
|
12.97
x
|
19.14
x
|
15.39
x
|
19.36
x
|
27.42
x
|
Free Cash Flow
1 |
-64.4
|
779
|
-460
|
986
|
-257
|
-265
|
ROE (net income / shareholders' equity)
|
-0.27%
|
4.9%
|
-6.13%
|
7.95%
|
-9.66%
|
-11.3%
|
ROA (Net income/ Total Assets)
|
2.47%
|
2.18%
|
1.79%
|
1.95%
|
1.78%
|
1.27%
|
Assets
1 |
-10,243
|
30,021
|
-36,383
|
33,125
|
-75,404
|
-94,754
|
Book Value Per Share
2 |
49.00
|
44.90
|
37.90
|
35.00
|
29.80
|
26.00
|
Cash Flow per Share
2 |
8.340
|
5.830
|
5.060
|
22.30
|
8.170
|
3.430
|
Capex
1 |
43
|
61
|
15
|
20
|
23
|
29
|
Capex / Sales
|
1.33%
|
2.19%
|
0.64%
|
0.86%
|
1.02%
|
1.19%
|
Announcement Date
|
3/18/19
|
4/7/20
|
3/31/21
|
3/23/22
|
3/29/23
|
4/11/24
|
Last Close Price
9.569
ILS Average target price
15
ILS Spread / Average Target +56.76% Consensus |